Meta-analysis of intravesical therapy for superficial bladder cancer: Superiority of Bacillus Calmette-Guerin may be confined to high risk patients

被引:0
|
作者
Shelley, MD
Court, J
Burgon, K
Coles, B
Kynaston, H
Wilt, T
Mason, MD
机构
[1] Velindre Hosp, Cochrane Unit, Cardiff CF14 2TL, S Glam, Wales
[2] Univ Wales Coll Med, Dept Urol, Cardiff CF4 4XW, S Glam, Wales
[3] Dept Vet Affairs, Minneapolis, MN 55417 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:53 / 53
页数:1
相关论文
共 50 条
  • [1] INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR PATIENTS WITH HIGH-RISK SUPERFICIAL BLADDER-CANCER
    KLIMBERG, IW
    POWSANG, JM
    CARTWRIGHT, CK
    WAJSMAN, Z
    UROLOGY, 1991, 37 (02) : 180 - 184
  • [2] Intravesical instillation therapy with bacillus Calmette-Guerin for superficial bladder cancer: Study of the mechanism of bacillus Calmette-Guerin immunotherapy
    Shintani, Yasuyo
    Sawada, Yoshihisa
    Inagaki, Takeshi
    Kohjimoto, Yasuo
    Uekado, Yasunari
    Shinka, Toshiaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (02) : 140 - 146
  • [3] INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER - EFFECT OF BACILLUS CALMETTE-GUERIN VIABILITY ON TREATMENT RESULTS
    KELLEY, DR
    RATLIFF, TL
    CATALONA, WJ
    SHAPIRO, A
    LAGE, JM
    BAUER, WC
    HAAFF, EO
    DRESNER, SM
    JOURNAL OF UROLOGY, 1985, 134 (01): : 48 - 53
  • [4] Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials
    Han, Rui Fa
    Pan, Jian Gang
    UROLOGY, 2006, 67 (06) : 1216 - 1223
  • [5] Intravesical bacillus Calmette-Guerin therapy for T1 superficial bladder cancer
    Demkow, Tomasz
    Alter, Andrzej
    Wiechno, Pawel
    UROLOGIA INTERNATIONALIS, 2008, 80 (01) : 74 - 79
  • [6] Cytological changes induced by intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer
    Takashi, M
    Schenck, U
    Koshikawa, T
    Nakashima, N
    Ohshima, S
    UROLOGIA INTERNATIONALIS, 2000, 64 (02) : 74 - 81
  • [7] PROSPECTIVE RANDOMIZED COMPARISON OF INTRAVESICAL WITH PERCUTANEOUS BACILLUS CALMETTE-GUERIN VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN IN SUPERFICIAL BLADDER-CANCER
    LAMM, DL
    DEHAVEN, JI
    SHRIVER, J
    SAROSDY, MF
    JOURNAL OF UROLOGY, 1991, 145 (04): : 738 - 740
  • [8] EXPERIENCE WITH BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER-TUMORS - VALUE OF MONOCYTE ACTIVATION IN INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY
    NISSENKORN, I
    LAVIE, G
    KEISARI, Y
    LEIB, Z
    VILCOVSKY, E
    SERVADIO, C
    SHACHTER, H
    EUROPEAN UROLOGY, 1987, 13 (04) : 246 - 250
  • [9] Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials
    Sylvester, RJ
    van der Meijden, APM
    Lamm, DL
    JOURNAL OF UROLOGY, 2002, 168 (05): : 1964 - 1970
  • [10] URINARY INTERLEUKINS IN PATIENTS RECEIVING INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER
    FLEISCHMANN, JD
    TOOSSI, Z
    ELLNER, JJ
    WENTWORTH, DB
    RATLIFF, TL
    IMBEMBO, AL
    CANCER, 1989, 64 (07) : 1447 - 1454